Navigation Links
All HIV Patients Should Take Meds Early On, Experts Now Say

MONDAY, July 23 (HealthDay News) -- A new report recommends that physicians begin treating all HIV-positive adults with antiretroviral drugs instead of waiting, at least in countries where the therapy is easily accessible.

All HIV-positive patients should take the drugs, even if blood tests reveal that their immune system is healthy, according to the revised guidelines, which were presented Sunday at the International AIDS Conference in Washington D.C., and published in the July 25 issue of the Journal of the American Medical Association.

Over the last 25 years, antiretroviral drugs have become stronger, easier to tolerate and simpler to take, the authors of the report explained. "New trial data and drug regimens that have become available in the last two years warrant an update to guidelines for antiretroviral therapy in HIV-infected adults in resource-rich settings," Dr. Melanie Thompson and her 2012 International Antiviral Society-USA Panel colleagues said in the report.

While medications don't rid the body of HIV -- the virus that causes AIDS -- they can prevent the virus from replicating and have allowed millions of people to live for years with a greatly reduced threat of developing AIDS, experts have noted.

However, not every person infected with HIV takes the medications. In some cases, doctors prefer to wait until a patient's immune system begins to show signs that the virus is becoming stronger.

The reasons why doctors sometimes wait to prescribe antiretroviral medications may be because the drugs can cause side effects, and there's also the challenge that patients must keep taking them or take the risk that the virus will rebound.

Commenting on the report, Rowena Johnston, director of research with the Foundation for AIDS Research in New York City, explained, "We can't lose sight of the fact that this is a big commitment. Once you start, you can't stop."

The report recommends that initial treatment include two nucleoside reverse transcriptase inhibitors (tenofovir/emtricitabine [brand name Truvada] or abacavir/lamivudine [known as ABC/3TC]) plus a non-nucleoside reverse transcriptase inhibitor (efavirenz [Sustiva]), a ritonavir-boosted protease inhibitor (atazanavir [Reyataz] or darunavir [Prezista], or an integrase strand transfer inhibitor (raltegravir [Isentress]).

The new guidelines are a sign of a "turning point" for HIV drugs, Johnston said. These medications are now being considered not only as a treatment but as a prevention tool because those who take them are less likely to infect other people, she noted. "The scientific community really recognizes how valuable they could be to prevent transmission," she said.

There are challenges, though, Johnston pointed out. One obstacle is money to pay for the drugs, even in rich countries such as the United States. There's also the matter of getting people to be tested in the first place and then to seek and retain medical care if they learn they are HIV-positive, she said.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about HIV and AIDS.

-- Randy Dotinga

SOURCES: Rowena Johnston, Ph.D., director, research, Foundation for AIDS Research, New York City; July 25, 2012, Journal of the American Medical Association

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Young Cancer Patients Often Lack Support: Study
2. Not All HIV Patients in U.S. Show Same Characteristics: Study
3. Increased cardiovascular risk in HIV-infected patients may relate to arterial inflammation
4. Among new HIV treatment recommendations, all adult patients should be offered antiretroviral therapy
5. Doctors Tend to Share Patients With Similar Colleagues
6. Many Medicaid Patients Skip Drugs That Could Prevent Heart Trouble
7. Meta-analysis: Interventions improve depression in cancer patients
8. CPAP treatment effective in patients with milder OSA and daytime sleepiness
9. Helping Alzheimers patients stay independent
10. New targeting technology improves outcomes for patients with atrial fibrillation
11. A stronger doctor-patient relationship for the costliest patients
Post Your Comments:
Related Image:
All HIV Patients Should Take Meds Early On, Experts Now Say
(Date:12/6/2019)... ... 2019 , ... Lasair Aesthetic Health Sponsors Toys for Tots to Give Free Toys to Children ... Bring in Toys During the Holidays , Lasair Aesthetic Health is spreading holiday cheer again ... bring in a toy or toys worth more than 25-dollars, will get FIVE units of ...
(Date:12/6/2019)... ... , ... TIME For Kids (TFK) revealed the first-ever list of ... fun destinations that are tailored to the interests of kids. The list identifies The ... the list, TIME for Kids gathered nominations from its network of TFK Kid ...
(Date:12/5/2019)... , ... December 05, 2019 , ... Abide, the #1 ... 25 million times this year using Bible-based bedtime stories. Listeners have recovered from bad ... According to the Center for Disease Control, one third of Americans suffer from poor ...
(Date:12/5/2019)... ... December 05, 2019 , ... It’s been an impactful year ... help people embrace, achieve, and maintain a healthy lifestyle to giving generously to ... our mission of impacting world health, so it’s gratifying to look back on ...
(Date:12/4/2019)... ... December 04, 2019 , ... Now a ... protection from disruptions to cells and tissue and inflammation that leads to Jet ... is available in a dietary supplement product called Prepair™ . , Today, ...
Breaking Medicine News(10 mins):
(Date:12/6/2019)... ... December 06, 2019 , ... The ... research, recently unveiled its bold new initiative to kickstart MSA research collaborations. ... of life. , Infused by $3 million in new bequests earmarked for research ...
(Date:12/5/2019)... ... December 05, 2019 , ... nView, ... Maurice Rosenbaum to the role of Chief Product Officer. As the company expands ... changing dynamics of the behavioral health market into nView’s product and company growth ...
(Date:12/4/2019)... , ... December 04, 2019 , ... ... planning, has announced the Top 17 Master's in Organizational Psychology Degree Programs for ... colleges and universities in the nation. Each program is evaluated based on curriculum ...
Breaking Medicine Technology: